Skip to main content
Premium Trial:

Request an Annual Quote

Edward Jensen

Blueprint Bio has appointed Edward Jenson as chief operating officer. He has over 30 years of leadership and managerial experience. Prior to joining Blueprint, Jenson held a number of senior leadership positions at major pharmaceutical companies including Johnson & Johnson, Biogen, AstraZeneca, and the TransCelerate industry collaboration.

The Scan

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.

Nature Papers Present Method to Uncover Differential RNA Modifications, Neutrophils in Innate Immune Response

In Nature this week: computational approach to identifying differential RNA modifications, and more.